Umlobi: Clyde Lopez
Usuku Lokudalwa: 24 Ujulayi 2021
Ukuvuselela Usuku: 15 Unovemba 2024
Anonim
Health Risks of Fucus Vesiculosus
Ividiyo: Health Risks of Fucus Vesiculosus

-Delile

I-Fucus vesiculosus uhlobo lwasolwandle olunsundu. Abantu basebenzisa isitshalo sonke ukwenza umuthi.

Abantu basebenzisa i-Fucus vesiculosus ngezimo ezinjengezinkinga ze-thyroid, ukuntuleka kwe-iodine, ukukhuluphala, nezinye eziningi, kodwa abukho ubufakazi obuhle besayensi bokusekela lokhu kusetshenziswa. Sebenzisa i-Fucus vesiculosus nakho kungaphepha.

Ungadidanisi i-Fucus vesiculosus ne-bladderwort.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze FUCUS VESICULOSUS zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Ukukhuluphala ngokweqile. Ucwaningo lokuqala lubonisa ukuthi ukuthatha i-Fucus vesiculosus kanye ne-lecithin namavithamini akusizi abantu ukuthi banciphise isisindo.
  • Isifo sikashukela.
  • Amalunga we-Achy (i-rheumatism).
  • Isifo samathambo.
  • "Ukuhlanzwa kwegazi".
  • Ukuqunjelwa.
  • Izinkinga zokugaya ukudla.
  • "Ukuqina kwemithambo yegazi" (i-arteriosclerosis).
  • Ukushoda kwe-iodine.
  • Izinkinga ze-thyroid, kufaka phakathi indlala yegilo esindayo (goiter).
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala ukusebenza kwe I-Fucus vesiculosus yalokhu kusetshenziswa.

I-Fucus vesiculosus iqukethe inani elingafani le-iodine. Iodine ingasiza ekuvikeleni noma ekwelapheni izinkinga ezithile ze-thyroid. I-Fucus vesiculosus nayo ingaba nemiphumela yokulwa nesifo sikashukela, futhi ingathinta amazinga e-hormone. Kepha imininingwane engaphezulu iyadingeka.

Lapho ithathwa ngomlomo: Fucus vesiculosus kuyinto MHLAWUMBI ANGIPHEPHILE. Ingaqukatha ukugxila okuphezulu kwe-iodine. Inani elikhulu le-iodine lingadala noma libe nzima izinkinga ezithile ze-thyroid. Futhi ingaqukatha izinsimbi ezisindayo, ezingadala ubuthi bensimbi esindayo.

Lapho isetshenziswa esikhunjeni: Fucus vesiculosus kuyinto OKUNGENZEKA UKUPHEPHA lapho isetshenziswa esikhumbeni.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Fucus vesiculosus kuyinto MHLAWUMBI ANGIPHEPHILE ukusebenzisa lapho ukhulelwe noma uncelisa ibele. Ungayisebenzisi.

Izinkinga zokopha: I-Fucus vesiculosus inganciphisa ukujiya kwegazi. Ngokombono, i-Fucus vesiculosus ingakhuphula ubungozi bokulimala noma ukopha kubantu abanezinkinga zokopha.

Isifo sikashukela: I-Fucus vesiculosus ingathinta amazinga kashukela egazini. Uma unesifo sikashukela futhi uthatha imishanguzo yokwehlisa ushukela wegazi, ukungeza ukuthi i-Fucus vesiculosus ingenza ushukela wegazi lakho wehle kakhulu. Bheka ishukela lakho egazini ngokucophelela.

Ukungabi nenzalo: Ucwaningo lokuqala luveza ukuthi ukuthatha i-Fucus vesiculosus kungenza kube nzima ukuthi abesifazane bakhulelwe.

Ukungezwani komzimba ne-iodine: I-Fucus vesiculosus iqukethe inani elikhulu le-iodine, elingadala ukungezwani komzimba nabantu ababucayi. Ungayisebenzisi.

Ukuhlinzwa: I-Fucus vesiculosus inganciphisa ukujiya kwegazi. Kukhona ukukhathazeka ukuthi kungadala ukopha okwengeziwe ngesikhathi nangemva kokuhlinzwa. Yeka ukuthatha i-Fucus vesiculosus okungenani amasonto ama-2 ngaphambi kokuhlinzwa.

Izinkinga ze-thyroid ezibizwa ngokuthi i-hyperthyroidism (i-hormone ye-thyroid eningi kakhulu), noma i-hypothyroidism (i-hormone ye-thyroid encane kakhulu): I-Fucus vesiculosus iqukethe inani elikhulu le-iodine, elingenza i-hyperthyroidism ne-hypothyroidism ibe yimbi kakhulu. Ungayisebenzisi.

Maphakathi
Qaphela ngale nhlanganisela.
ILithium
I-Fucus vesiculosus ingaqukatha inani elikhulu le-iodine. Iodine ingathinta i-thyroid. ILithium nayo ingathinta igilo. Ukuthatha iodine kanye ne-lithium kungakhuphula i-thyroid kakhulu.
Imithi ye-thyroid engasebenzi ngokweqile (izidakamizwa ze-Antithyroid)
I-Fucus vesiculosus ingaqukatha inani elikhulu le-iodine. Iodine ingathinta i-thyroid. Ukuthatha iodine kanye nemithi ye-thyroid engasebenzi ngokweqile kunganciphisa i-thyroid kakhulu, noma kungathinta ukuthi imithi ye-antithyroid isebenza kanjani. Ungathathi i-Fucus vesiculosus uma uphuza imithi yegilo.

Eminye yale mithi ifaka phakathi i-methimazole (Tapazole), i-potassium iodide (Thyro-Block), neminye.
Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)
I-Fucus vesiculosus inganciphisa ukujiya kwegazi. Ukuthatha i-Fucus vesiculosus kanye nemithi nayo ejija kancane ukuvimba kungandisa amathuba okulinyazwa nokopha.

Eminye imishanguzo eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, abanye), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox) , heparin, warfarin (Coumadin), nabanye.
Okuncane
Qaphela ngale nhlanganisela.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C8 (CYP2C8))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Fucus vesiculosus ingahle inciphise ukuthi isibindi sehlisa kanjani imithi ethile ngokushesha. Sebenzisa i-Fucus vesiculosus kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi eminye yale mithi.
Eminye imithi eshintshwe yisibindi ifaka i-amiodarone (Cardarone), paclitaxel (Taxol); izidakamizwa ezingezona ukuvuvukala (ama-NSAID) njenge-diclofenac (i-Cataflam, i-Voltaren) ne-ibuprofen (i-Motrin); i-rosiglitazone (i-Avandia); nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C9 (CYP2C9))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Fucus vesiculosus ingahle inciphise ukuthi isibindi sehlisa kanjani imithi ethile ngokushesha. Sebenzisa i-Fucus vesiculosus kanye neminye imishanguzo eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi eminye yale mithi.
Eminye imishanguzo eguqulwe isibindi ifaka phakathi izidakamizwa ezingezona ukuvuvukala (ama-NSAID) njenge-diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), ne-piroxicam (Feldene); i-celecoxib (Celebrex); i-amitriptyline (u-Elavil); i-warfarin (i-Coumadin); i-glipizide (iGlucotrol); losartan (Cozaar); nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2D6 (CYP2D6))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Fucus vesiculosus ingakhuphula noma inciphise ukuthi isibindi sehlisa kanjani imithi ethile ngokushesha. Sebenzisa i-Fucus vesiculosus kanye neminye imishanguzo eyehliswe isibindi kungakhuphula noma kwehlise imiphumela nemiphumela engemihle yeminye yale mithi.
Eminye imishanguzo eguqulwe isibindi ifaka i-amitriptyline (Elavil), i-codeine, i-desipramine (i-Norpramin), i-flecainide (i-Tambocor), i-haloperidol (i-Haldol), i-imipramine (i-Tofranil), i-metoprolol (i-Lopressor, i-Toprol XL), i-ondansetron (i-Zofran), i-paroxetine (i-Paxiletine) ), risperidone (Risperdal), tramadol (Ultram), venlafaxine (Effexor), nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 3A4 (CYP3A4))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Fucus vesiculosus ingahle inciphise ukuthi isibindi sehlisa kanjani imithi ethile ngokushesha. Sebenzisa i-Fucus vesiculosus kanye neminye imishanguzo eyehliswe isibindi kungakhuphula imiphumela kanye nemiphumela engemihle yeminye yale mithi.
Eminye imithi eshintshwe yisibindi ihlanganisa i-alprazolam (Xanax), i-amlodipine (i-Norvasc), i-clarithromycin (i-Biaxin), i-cyclosporine (iSandimmune), i-erythromycin, i-lovastatin (i-Mevacor), i-ketoconazole (i-Nizoral), i-itraconazole (i-Sporanox), i-fexofenadine (Halcion), verapamil (Calan, Isoptin) nabanye abaningi.
Amakhambi nezengezo ezinganciphisa ukujiya kwegazi
I-Fucus vesiculosus inganciphisa ukujiya kwegazi. Ukuthatha i-Fucus vesiculosus kanye namakhambi nawo ajiya kancane kungakhuphula amathuba okulinyazwa nokopha. Lawa makhambi afaka i-angelica, i-clove, i-danshen, i-fenugreek, i-feverfew, i-garlic, i-ginger, i-ginkgo, i-Panax ginseng, i-poplar, i-red clover, i-turmeric, nezinye.
IStrontium
I-Fucus vesiculosus iqukethe i-alginate. I-Alginate inganciphisa ukumuncwa kwe-strontium. Ukuthatha i-Fucus vesiculosus ngezithako ze-strontium kunganciphisa ukumuncwa kwe-strontium.
Akukho ukuxhumana okwaziwayo nokudla.
Umthamo ofanele we I-Fucus vesiculosus kuya ngezinto eziningi ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi, alukho ulwazi olwanele lwesayensi lokunquma uhla olufanele lwamanani we-Fucus vesiculosus. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

IBlack Tang, Isinye Fucus, Isinye Wrack, Bladderwrack, Blasentang, Cutweed, Dyer's Fucus, Fucus Vésiculeux, Goémon, Kelp, Kelpware, Kelp-Ware, Ocean Kelp, Quercus Marina, Red Fucus, Rockwrack, Sea Kelp, Sea Oak, Seawrack, IVarech, iVarech Vésiculeux.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. UHeavisides E, uRouger C, Reichel AF, et al. Ukuhluka Kwesizini kuphrofayili yeMetabolome kanye ne-Bioactivity ye-Fucus vesiculosus ekhishwe yi-Optimised, Pressurized Liquid Extraction Protocol. Izidakamizwa zikaMar. 2018; 16. pii: E503. Buka okungaqondakali.
  2. UDerosa G, uCicero AFG, uD'Angelo A, uMaffioli P. Ascophyllum nodosum noFucus vesiculosus ngesimo se-glycemic nakuma-endothelial umonakalo wokumaka ezigulini ze-dysglicemic. I-Phytother Res. 2019; 33: 791-797. Buka okungaqondakali.
  3. UMathew L, uBurney M, uGaikwad A, et al. Ukuhlolwa kwangaphambili kokuphepha kokukhishwa kwe-fucoidan kusuka e-Undaria pinnatifida naseFucus vesiculosus okusetshenziselwa ukwelashwa komdlavuza. I-Cancer Ther ehlanganisiwe 2017; 16: 572-84. Buka okungaqondakali.
  4. I-Wikström SA, i-Kautsky L. Isakhiwo nokwehluka kwemiphakathi engenamgogodla ebukhoneni nokungabikho kwe-canopy-kutengeneza Fucus vesiculosus oLwandle iBaltic. I-Estuarine Coastal Shelf Sci 2007; 72: 168-176.
  5. UTorn K, uKrause-Jensen D, uMartin G. Ukusatshalaliswa kwamanje kwe-bladderwrack (Fucus vesiculosus) nolwandle lwaseBaltic. I-Aquatic Botany 2006; 84: 53-62.
  6. I-Alraei, RG. Izithako Zemithi Nezokudla Zokwehlisa Isisindo. Izihloko ku-Clinical Nutrition. 2010; 25: 136-150.
  7. UBradley MD, uNelson A Petticrew M Cullum N Sheldon T. Ukugqoka izilonda zengcindezi. Umtapo Wezincwadi waseCochrane 2011; 0: 0.
  8. USchreuder SM, uVermeulen H Qureshi MA Ubbink DT. Ukugqokiswa kanye nama-topical agents wezindawo zabanikeli bokuqothulwa kwesikhumba okuhlukanisiwe. I-JOURNAL 2009; 0: 0.
  9. UMartyn-St James M., u-O'Meara S. Ukugqokwa kwamagwebu ezilonda zomlenze ezinobuthi. Umtapo Wezincwadi WaseCochrane. 2012; 0: 0.
  10. U-Ewart, uS Girouard G. Tiller C. et al. Imisebenzi ye-Antidiabetic ye-Seaweed Extract. Isifo sikashukela. 2004; 53 (Isengezo 2): A509.
  11. Lindsey, H. Ukusetshenziswa kweBotanicals yeCancer: Kudingeka Ucwaningo Oluhlelekile Ukunquma Indima. Izikhathi ze-Oncology. 2005; 27: 52-55.
  12. ULe Tutour B, uBenslimane F, iGouleau MP, no-al. Imisebenzi ye-antioxidant kanye ne-pro-oxidant ye-algae ensundu, iLaminaria digitata, i-Himanthalia elongata, i-Fucus vesiculosus, i-Fucus serratus ne-Ascophyllum nodosum. J I-Applied Phycology 1998; 10: 121-129.
  13. U-Eliason, B. C. I-hyperthyroidism yesikhashana esigulini ethatha izithako zokudla eziqukethe i-kelp. J Am Board Fam Khipha. 1998; 11: 478-480. Buka okungaqondakali.
  14. UGaigi, S., Elati, J., Ben, Osman A., noBeji, C. [Ucwaningo lokuhlola ngemiphumela yezimila zasolwandle ekwelapheni ukukhuluphala]. I-Tunis Med. 1996; 74: 241-243. Buka okungaqondakali.
  15. UDrozhzhina, V. A., Fedorov, IuA, Blokhin, V. P., Soboleva, T. I., noKazakova, O. V. [Ukusetshenziswa kwamakhemikhali amazinyo asuselwa ezintweni zemvelo ezisebenza ekwelapheni nasekuvikeleni izifo ze-periodontal]. IStomatologiia (Mosk) 1996; Inombolo ecacisiwe: 52-53. Buka okungaqondakali.
  16. Yamamoto I, Nagumo T, Fujihara M, futhi et al. Umphumela we-Antitumor wezimila zasolwandle. II. Ukwahlukaniswa nokuhlukaniswa okuyingxenye ye-polysaccharide ngomsebenzi we-antitumor kusuka eSargassum fulvellum. I-Jpn. J Exp Med 1977; 47: 133-140. Buka okungaqondakali.
  17. UMonego, E. T., Peixoto, Mdo R., Jardim, P. C., Sousa, A. L., Braga, V. L., noMoura, M. F. [Imithi ehlukene ekwelapheni ukukhuluphala kweziguli ezine-hypertensive]. I-Arq Bras. Cardiol. 1996; 66: 343-347. Buka okungaqondakali.
  18. URiou D, uColliec-Jouault S, uPinczon du Sel D, no-al. Imiphumela ye-antitumor kanye ne-antiproliferative ye-fucan ekhishwe ku-ascophyllum nodosum emelene non-small-cell bronchopulmonary carcinoma line. I-Anticancer Res 1996; 16 (3A): 1213-1218. Buka okungaqondakali.
  19. I-Sakata, T. I-calorie ejwayelekile ephansi kakhulu yokudla kwaseJapan: imiphumela yayo ekuvimbeleni ukukhuluphala. Obes. 1995; 3 Isigaba 2: 233s-239s. Buka okungaqondakali.
  20. U-Ellouali M, uBoisson-Vidal C, uDurand P, no-al. Umsebenzi we-Antitumor wama-molecular fucans aphansi akhishwe ku-Ascophyllum nodosum brown. I-Anticancer Res 1993; 13 (6A): 2011-2020. Buka okungaqondakali.
  21. UDrnek, F., Prokes, B., noRydlo, O. [Isivivinyo sokuthinta umdlavuza ngokwemvelo ngokuphathwa kwezinambuzane zasolwandle, iScenedesmus obliquus]. UCesk.Gynekol. 1981; 46: 463-465. Buka okungaqondakali.
  22. UCriado, M. T. noFerreiros, C. M. Ukuxhumana okukhethiwe kweFucus vesiculosus lectin-like mucopolysaccharide enezinhlobo eziningi zeCandida. U-Ann Microbiol (eParis) 1983; 134A: 149-154. Buka okungaqondakali.
  23. UShilo, S. noHirsch, H. J. Iodine-eyenga i-hyperthyroidism esigulini esinendlala ejwayelekile yegilo. I-Postgrad Med J 1986; 62: 661-662. Buka okungaqondakali.
  24. IChurch FC, uMeade JB, uTreanor RE, no-al. Umsebenzi we-Antithrombin we-fucoidan. Ukusebenzisana kwe-fucoidan ne-heparin cofactor II, i-antithrombin III, ne-thrombin. J Biol Chem 2-25-1989; 264: 3618-3623. Buka okungaqondakali.
  25. UGrauffel V, uKloareg B, uMabeau S, no-al. Ama-polysaccharides amasha emvelo anomsebenzi onamandla we-antithrombic: ama-fucans avela ku-algae ansundu. Ama-Biomaterials 1989; 10: 363-368. Buka okungaqondakali.
  26. ULamela M, Anca J, Villar R, no-al. Umsebenzi we-Hypoglycemic wezinto ezimbalwa ezikhishwe olwandle. J. Ethnopharmacol. 1989; 27 (1-2): 35-43. Buka okungaqondakali.
  27. UMaruyama H, uNakajima J, no-Yamamoto I. Ucwaningo ngemisebenzi ye-anticoagulant ne-fibrinolytic ye-fucoidan engahluziwe evela kolwandle oludliwayo oludliwayo Laminaria religiosa, ngokubhekiswe ngokukhethekile kumthelela wayo wokuvimbela ukukhula kwama-sarcoma-180 ascites cell afakwe ngaphakathi kwamagundane . I-Kitasato Arch Exp Med 1987; 60: 105-121. Buka okungaqondakali.
  28. Obiero, J., Mwethera, P. G., noWiysonge, C. S. Ama-microbicides wokuvikela izifo ezithathelwana ngocansi. Idatha yedatha yeCochrane. 2012; 6: CD007961. Buka okungaqondakali.
  29. I-Park, KY, Jang, WS, Yang, GW, Rho, YH, Kim, BJ, Mun, SK, Kim, CW, noKim, MN Ucwaningo lomshayeli wendwangu yesiliva elayishwe isiliva enezimila zasolwandle ezifakiwe zokwelapha i-atopic dermatitis . Umtholampilo.Exp.Dermatol. 2012; 37: 512-515. Buka okungaqondakali.
  30. UMichikawa, T., Inoue, M., Shimazu, T., Sawada, N., Iwasaki, M., Sasazuki, S., Yamaji, T., noTsugane, S. Ukusetshenziswa kolwandle kanye nobungozi bomdlavuza we-thyroid kwabesifazane : Isifundo Esilindelekile EsiseJapane Sezempilo Yomphakathi. I-Eur.J Cancer Prev. 2012; 21: 254-260. Buka okungaqondakali.
  31. UCapitanio, B., Sinagra, J. L., Weller, R. B., Brown, C., noBerardesca, E. Ucwaningo olulawulwa ngokungahleliwe lokwelashwa kwezimonyo lomqubuko omncane. Umtholampilo.Exp.Dermatol. 2012; 37: 346-349. Buka okungaqondakali.
  32. UMarais, D., Gawarecki, D., Allan, B., Ahmed, K., Altini, L., Cassim, N., Gopolang, F., Hoffman, M., Ramjee, G., noWillionon, AL The ukusebenza kweCarraguard, i-microbicide yesitho sangasese sowesifazane, ekuvikeleni abesifazane ekuthelelekeni nge-papillomavirus yabantu abasengozini enkulu. Isivikelo. 2011; 16: 1219-1226. Buka okungaqondakali.
  33. U-Cho, H. B., Lee, H. H., Lee, O. H., Choi, H. S., Choi, J. S., no-Lee, B. Y. Ukuhlolwa kwemitholampilo kanye ne-microbial yemiphumela ku-gingivitis yomlomo wokuhlanza umlomo oqukethe i-Enteromorpha linza extract. J.Med.Ukudla 2011; 14: 1670-1676. Buka okungaqondakali.
  34. I-Kang, YM, Lee, BJ, Kim, JI, Nam, BH, Cha, JY, Kim, YM, Ahn, CB, Choi, JS, Choi, IS, noJe, i-JY Imiphumela ye-Antioxidant yothango lwasolwandle olubilisiwe (Laminaria japonica) nguLactobacillus brevis BJ20 kubantu abanezinga eliphakeme le-gamma-GT: Ucwaningo lomtholampilo olulawulwa ngokungahleliwe, oluyimpumputhe, nolulawulwa yi-placebo. Ukudla Chem. I-Toxicol. 2012; 50 (3-4): 1166-1169. Buka okungaqondakali.
  35. U-Arbaizar, B. noLlorca, J. [UFucus vesiculosus wenza i-hyperthyroidism esigulini eselashwa ngokuhambisana ne-lithium]. I-Actas Esp. IPsiquiatr. 2011; 39: 401-403. Buka okungaqondakali.
  36. IHholo, A. C., Fairclough, A. C., Mahadevan, K., noPaxman, J. R. Ascophyllum nodosum okucebile isinkwa kunciphisa ukulandela amandla okulandelayo kungabi namthelela ku-post-prandial glucose ne-cholesterol emadodeni anempilo, anesisindo esikhulu. Isifundo sokushayela indiza. Ukudla ngo-2012; 58: 379-386. Buka okungaqondakali.
  37. UParadis, M. E., Couture, P., noLamarche, B. Isivivinyo esilawulwa ngokungahleliwe se-crossover placebo esilawula umphumela we-brownweed (Ascophyllum nodosum neFucus vesiculosus) ku-postchallenge glucose glucose namazinga e-insulin kwabesilisa nabesifazane. I-Appl Physiol Nutr. Metab 2011; 36: 913-919. Buka okungaqondakali.
  38. IMisurcova, L., Machu, L., ne-Orsavova, J. Amaminerali asolwandle njengama-nutraceuticals. I-Adv. Ukudla okunomsoco. 2011; 64: 371-390. Buka okungaqondakali.
  39. UJeukendrup, A. E. noRandell, R. Izishiseli zamafutha: izithasiselo zokudla okunomsoco okwandisa imetabolism yamafutha. Obes. 2011; 12: 841-851. Buka okungaqondakali.
  40. I-Shin, i-HC, i-Kim, i-SH, i-Park, i-Y., i-Lee, i-BH ne-Hwang, i-HJ Imiphumela ye-supplementation yomlomo yamaviki ayi-12 ye-Ecklonia cava polyphenols kuma-anthropometric negazi lipid parameter kubantu abakhuluphele baseKorea: isilingo somtholampilo esimpumputhe . I-Phytother.Res. 2012; 26: 363-368. Buka okungaqondakali.
  41. UPangestuti, R. noKim, S. K. Imiphumela ye-Neuroprotective yama-algae ulwandle. Mar.Izidakamizwa 2011; 9: 803-818. Buka okungaqondakali.
  42. UMiyashita, K., Nishikawa, S., Beppu, F., Tsukui, T., Abe, M., noHosokawa, M. I-allenic carotenoid fucoxanthin, i-novelineaceaceutical yasolwandle evela kulwandle lwasolwandle onsundu. J.Sci.Izolimo Zokudla. 2011; 91: 1166-1174. Buka okungaqondakali.
  43. U-Araya, N., Takahashi, K., Sato, T., Nakamura, T., Sawa, C., Hasegawa, D., Ando, ​​H., Aratani, S., Yagishita, N., Fujii, R., U-Oka, H., Nishioka, K., Nakajima, T., Mori, N., no-Yamano, Y. Ukwelashwa kweFucoidan kunciphisa umthwalo we-proviral ezigulini ezine-T-lymphotropic virus type-1-related neurological disease. Isivikelo. 2011; 16: 89-98. Buka okungaqondakali.
  44. O, J. K., Shin, Y. O., Yoon, J. H., Kim, S. H., Shin, H. C., noHwang, H. J. Umphumela wokwengeza ne-Ecklonia cava polyphenol ekusebenzeni kokukhuthazela kwabafundi basekolishi. Int.J.Izemidlalo Nutr.Exerc.Metab 2010; 20: 72-79. Buka okungaqondakali.
  45. Odunsi, ST, Vazquez-Roque, MI, Camilleri, M., Papathanasopoulos, A., Clark, MM, Wodrich, L., Lempke, M., McKinzie, S., Ryks, M., Burton, D., no I-Zinsmeister, i-AR Umphumela we-alginate kusuthi, isifiso sokudla, ukusebenza kwesisu, namahomoni akhethiwe we-gut satiety ekukhulupheni ngokweqile nokukhuluphala. Ukukhuluphala. (Isilivere.Spring) 2010; 18: 1579-1584. Buka okungaqondakali.
  46. Teas, J., Baldeon, M. E., Chiriboga, D. E., Davis, J. R., Sarries, A. J., noBraverman, L. E. Ngabe ukudla kwasolwandle okudliwayo kungasibuyisela emuva lesi sifo se-metabolic? I-Asia Pac. J. Clin. Umsoco. U-2009; 18: 145-154. Buka okungaqondakali.
  47. U-Irhimeh, M. R., Fitton, J.H, noLowenthal, R. M. Pilot isifundo somtholampilo sokuhlola umsebenzi we-anticoagulant we-fucoidan. Igazi Coagul. I-fibrinolysis 2009; 20: 607-610. Buka okungaqondakali.
  48. UFluhr, JW, Breternitz, M., Kowatzki, D., Bauer, A., Bossert, J., Elsner, P., noHubler, i-UC Silver-ulayishwe ulwandle olwe-cellulosic fiber ithuthukisa isikhumba se-epidermal physiology ku-atopic dermatitis: ukuphepha ukuhlolwa, indlela yokusebenza kanye nokuhlola, okungahleliwe okuhlola okungahleliwe esifundweni se-vivo. Exp. I-dermatol. 2010; 19: e9-15. Buka okungaqondakali.
  49. UVasilevskaia, L. S., Pogozheva, A. V., Derbeneva, S. A., Zorin, S. N., Buchanova, A. V., Abramova, L. S., Petrukhanova, A. V., Gmoshinskii, I. V., noMazo, V. K. [Ukusebenza kahle kwemitholampilo yokusebenzisa ujamu we-laminaria ohlanganiswe ne-selenium]. I-Vopr. IPitan. U-2009; 78: 79-83. Buka okungaqondakali.
  50. UFrestedt, J. L., Kuskowski, M. A., noZenk, J. L. Isengezo semvelo semithombo yolwandle esuselwe olwandle (i-Aquamin F) yamadolo i-osteoarthritis: isifundo somshayeli we-placebo esilawulwa ngokungahleliwe. Umsoco. J. 2009; 8: 7. Buka okungaqondakali.
  51. UWasiak, J., Cleland, H., noCampbell, F. Ukugqokiswa kokusha okungaphezulu nokungaphelele. Idatha yedatha yeCochrane. 2008; CD002106. Buka okungaqondakali.
  52. UFowler, E. noPapen, J. C. Ukuhlolwa kokugqokwa kwe-alginate kwezilonda zengcindezi. I-Decubitus. 1991; 4: 47-8, 50, 52. Buka okungaqondakali.
  53. UPaxman, J. R., Richardson, J. C., Dettmar, P. W., noCorfe, B. M. Ukungeniswa kwansuku zonke kwe-alginate kunciphisa ukusetshenziswa kwamandla kuzihloko eziphila mahhala. Ukudla kwe-2008; 51: 713-719. Buka okungaqondakali.
  54. UFrestedt, J. L., Walsh, M., Kuskowski, M. A., noZenk, J. L. Isengezo semvelo samaminerali sinikeza ukukhululeka kwizimpawu zamadolo i-osteoarthritis: isilingo somshayeli esilawulwa ngokungahleliwe. Umsoco J 2008; 7: 9. Buka okungaqondakali.
  55. UColliec S, uFischer AM, uTapon-Bretaudiere J, no-et al. Izici ze-Anticoagulant zengxenyenamba ye-fucoidan. I-Thromb Res 10-15-1991; 64: 143-154. Buka okungaqondakali.
  56. URowe, B. R., Bain, S. C., Pizzey, M., noBarnett, A. H. Ukupholisa ngokushesha kwe-ulcerated necrobiosis lipoidica ngokulawula okuhle kwe-glycemic nokugqokwa okususelwa olwandle. UBr. J. Dermatol. 1991; 125: 603-604. Buka okungaqondakali.
  57. Teas, J., Braverman, L. E., Kurzer, M. S., Pino, S., Hurley, T. G., noHebert, J. R. Seaweed kanye nesoya: ukudla okuhambisana nokudla kwase-Asia nemiphumela yako ekusebenzeni kwe-thyroid kwabesifazane baseMelika. J Med Ukudla 2007; 10: 90-100. Buka okungaqondakali.
  58. UCumashi, A., Ushakova, NA, Preobrazhenskaya, ME, D'Incecco, A., Piccoli, A., Totani, L., Tinari, N., Morozevich, GE, Berman, AE, Bilan, MI, Usov, AI , Ustyuzhanina, NE, Grachev, AA, Sanderson, CJ, Kelly, M., Rabinovich, GA, Iacobelli, S., noNifantiev, NE Ucwaningo lokuqhathanisa lwemisebenzi elwa nokuvuvukala, i-anticoagulant, antiangiogenic, ne-antiadhesive yemisebenzi eyisishiyagalolunye ehlukene ama-fucoidans avela kolwandle lwasolwandle onsundu. IGlycobiology 2007; 17: 541-552. Buka okungaqondakali.
  59. UNelson, E. A. noBradley, M. D. Ukugqoka kanye nama-topical agents wezilonda zemilenze yomthambo. Idatha yedatha yeCochrane. 2007; CD001836. Buka okungaqondakali.
  60. UPalfreyman, S. J., Nelson, E. A., Lochiel, R., noMichaels, J. A. Ukugqoka okwelapha izilonda zemilenze ezinobuthi. Idatha yedatha yeCochrane. 2006; CD001103. Buka okungaqondakali.
  61. UMaeda, H., Hosokawa, M., Sashima, T., Takahashi, N., Kawada, T., noMiyashita, K. Fucoxanthin kanye ne-metabolite yayo, i-fucoxanthinol, icindezela ukuhlukaniswa kwe-adipocyte kumaseli we-3T3-L1. Int.J.Mol.Med. 2006; 18: 147-152. Buka okungaqondakali.
  62. URudichenko, E. V., Gvozdenko, T. A., no-Antoniuk, M. V. [Impact of dietotherapy with enterosorbent of marine origin on the indices of mineral and lipid metabolism for iziguli ezinezifo zezinso]. I-Vopr. IPitan. 2005; 74: 33-35. Buka okungaqondakali.
  63. USoeda S, uSakaguchi S, uShimeno H, no-al. Imisebenzi ye-fibrinolytic ne-anticoagulant ye-fucoidan enesibabuli kakhulu. I-Biochem Pharmacol 4-15-1992; 43: 1853-1858. Buka okungaqondakali.
  64. UVermeulen, H., Ubbink, D., uGoossens, A., de, Vos R., noLegemate, D. Ukugqoka kanye nama-topical agents okuphulukisa amanxeba okuhlinzwa ngenhloso yesibili. Idatha yedatha yeCochrane. 2004; CD003554. Buka okungaqondakali.
  65. U-SPRINGER, G. F., WURZEL, H. A., noMcneal, G. M. et al. Ukuhlukaniswa kwezingxenyana ze-anticoagulant kusuka ku-fucoidin ongahluziwe. I-Proc.Soc.Exp.Biol.I-Meded 1957; 94: 404-409. Buka okungaqondakali.
  66. UBell, J., uDuhon, S., noDokotela, uV. M. Umphumela we-fucoidan, heparin kanye ne-cyanogen bromide-fibrinogen ekusebenzeni kwe-glutamic-plasminogen yabantu yi-activator ye-plasminogen. Igazi Coagul. I-fibrinolysis 2003; 14: 229-234. Buka okungaqondakali.
  67. Cooper, R., Dragar, C., Elliot, K., Fitton, J. H., Godwin, J., noThompson, K. GFS, ukulungiswa kweTasmanian Undaria pinnatifida kuhlotshaniswa nokuphilisa nokuvimbela ukuvuselelwa kwe-Herpes. BMC.Complement Altern.Med. 11-20-2002; 2: 11. Buka okungaqondakali.
  68. Abidov, M., Ramazanov, Z., Seifulla, R., noGrachev, S. Imiphumela yeXanthigen ekuphathweni kwesisindo sabesifazane abakhuluphele be-premenopausal abanezifo zesibindi ezinamafutha ezingezona utshwala kanye namafutha wesibindi ajwayelekile. Isifo Sikashukela Imethab 2010; 12: 72-81. Buka okungaqondakali.
  69. I-Lis-Balchin, M. Ucwaningo lomtholampilo olulawulwa nge-placebo lwenhlanganisela yamakhambi athengiswa njengekhambi le-cellulite. I-Phytother.Res. 1999; 13: 627-629. Buka okungaqondakali.
  70. UCatania, M. A., Oteri, A., Caiello, P., Russo, A., Salvo, F., Giustini, E. S., Caputi, A. P., noPolimeni, G. Hemorrhagic cystitis ebangelwa yingxube yamakhambi. ENingizimu.I-Med.J. 2010; 103: 90-92. Buka okungaqondakali.
  71. Bezpalov, V. G., Barash, N. I., Ivanova, O. A., Semenov, I. I., Aleksandrov, V. A., noSemiglazov, V. F. [Ukuphenywa kwesidakamizwa "iMamoclam" ekwelapheni iziguli ezine-fibroadenomatosis yebele]. I-Vopr. I-Onkol. 2005; 51: 236-241. Buka okungaqondakali.
  72. Dumelod, B. D., Ramirez, R. P., Tiangson, C. L., Barrios, E. B., and Panlasigui, L. N. Ukutholakala kwe-carbohydrate ye-arroz caldo ne-lambda-carrageenan. Int. J. Ukudla Isayensi. 1999; 50: 283-289. Buka okungaqondakali.
  73. UBurack, J. H., Cohen, M. R., Hahn, J. A., no-Abrams, D. I. Isilingo esilawulwa ngokungahleliwe sokwelapha amakhambi amaShayina ngezimpawu ezihlobene ne-HIV. J Acquir.Imune.Defic.Syndr.Hum.Retrovirol. 8-1-1996; 12: 386-393. Buka okungaqondakali.
  74. UMnyango Wezempilo kanye Nezinsizakalo Zabantu e-US, iNkonzo Yezempilo Yomphakathi. Isikhungo Sokubhaliswa Kwezinto Eziyingozi kanye Nezifo. Iphrofayili enobuthi ye-strontium. Ephreli 2004. Itholakala ku: www.atsdr.cdc.gov/toxprofiles/tp159.pdf. (Kufinyelelwe ngomhla ka-8 Agasti 2006).
  75. I-Agarwal SC, uCrook JR, uPepper CB. Amakhambi esintu - aphephe kangakanani? Umbiko wecala le-polymorphic ventricular tachycardia / fibrillation ye-ventricular eyenziwe yimithi yamakhambi esetshenziselwa ukukhuluphala. I-Int J Cardiol 2006; 106: 260-1. Buka okungaqondakali.
  76. U-Okamura K, Inoue K, u-Omae T. Icala le-Hashimoto's thyroiditis eline-thyroid immunological normal elivezwa ngemuva kokungenisa umkhuba wolwandle. I-Acta Endocrinol (Copenh) 1978; 88: 703-12. Buka okungaqondakali.
  77. UBjorvell H, Rössner S. Imiphumela yesikhathi eside yezinhlelo ezejwayelekile zokunciphisa isisindo eSweden. I-Int J Obes 1987; 11: 67-71. . Buka okungaqondakali.
  78. U-Ohye H, uFukata S, uKanoh M, et al. I-Thyrotoxicosis ebangelwa ukuncipha kwesisindo semithi yamakhambi. I-Arch Intern Med 2005; 165: 831-4. Buka okungaqondakali.
  79. UConz PA, uLa Greca G, uBenedetti P, et al. I-Fucus vesiculosus: i-alph ne-nephrotoxic? Ukufakelwa kweNephrol Dial 1998; 13: 526-7. Buka okungaqondakali.
  80. UFujimura T, Tsukahara K, Moriwaki S, et al. Ukwelashwa kwesikhumba somuntu ngokukhishwa kwe-Fucus vesiculosus kushintsha ukujiya nezakhiwo zemishini. J Cosmet Sci 2002; 53: 1-9. Buka okungaqondakali.
  81. UKoyanagi S, Tanigawa N, Nakagawa H, et al. Ukwanda ngokweqile kwe-fucoidan kuthuthukisa imisebenzi yayo yokulwa ne-angiogenic kanye ne-antitumor. I-Biochem Pharmacol 2003; 65: 173-9. Buka okungaqondakali.
  82. UDurig J, uBruhn T, uZurborn KH, et al. Izingxenyana ze-Anticoagulant fucoidan ezivela ku-Fucus vesiculosus zenza kusebenze iplatelet in vitro. IThromb Res 1997; 85: 479-91. Buka okungaqondakali.
  83. U-O'Leary R, ​​uRerek M, uWood EJ. IFucoidan iguqula umphumela wokuguqula ukukhula kwesici (i-TGF) -beta1 kukwanda kwe-fibroblast nokwanda kwesilonda kumamodeli we-vitro wokulungiswa kwesilonda sederm. I-Biol Pharm Bull 2004; 27: 266-70. Buka okungaqondakali.
  84. UPatankar MS, u-Oehninger S, uBarnett T, et al. Isakhiwo esibuyekeziwe se-fucoidan singachaza eminye yemisebenzi yaso yemvelo. UJ Biol Chem 1993; 268: 21770-6. Buka okungaqondakali.
  85. UBaba M, uSnoeck R, uPauwels R, de Clercq E. Ama-polysaccharides ashubile angama-inhibitors anamandla futhi ayakhetha amagciwane ahlukahlukene ahlanganisiwe, kufaka phakathi i-herpes simplex virus, i-cytomegalovirus, i-vesicular stomatitis virus, ne-human immunodeficiency virus. Ama-Antimicrob Agents Chemother 1988; 32: 1742-5. Buka okungaqondakali.
  86. URuperez P, Ahrazem O, Leal JA. Amandla we-antioxidant anamandla we-polysaccharides enesibabule avela kolwandle oludliwayo lolwandle olumnyama olunguFucus vesiculosus. J Agric Ukudla Chem 2002; 50: 840-5. Buka okungaqondakali.
  87. UBeress A, uWassermann O, uTahhan S, et al. Inqubo entsha yokuhlukaniswa kwama-anti-HIV compounds (ama-polysaccharides nama-polyphenols) avela ku-alga alga Fucus vesiculosus. UJ Nat Prod 1993; 56: 478-88. Buka okungaqondakali.
  88. ICriado MT, iFerreiros CM. Ubuthi be-algal mucopolysaccharide yezinhlobo ze-Escherichia coli ne-Neisseria meningitidis. UMfu Esp Fisiol 1984; 40: 227-30. Buka okungaqondakali.
  89. ISkibola CF. Umphumela we-Fucus vesiculosus, i-seaweed edliwayo ensundu, kubude bomjikelezo wokuya esikhathini kanye nesimo se-hormonal kwabesifazane abathathu bangaphambi kokuya esikhathini: umbiko wecala. I-BMC Complement Altern Med 2004; 4: 10. Buka okungaqondakali.
  90. UPhanauf D, uCote I, uDumas P, et al. Ukuhlolwa kokungcola kwe-algae algae (Seaweed) kusuka eMfuleni iSt. Lawrence futhi kungenzeka kudliwe ngabantu. I-Environ Res 1999; 80: S175-S182. Buka okungaqondakali.
  91. I-Baker DH. Ubuthi be-iodine kanye nokuvuselelwa kwayo. I-Exp Biol Med (Maywood) 2004; 229: 473-8. Buka okungaqondakali.
  92. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezikhombo Zezokudla ku-Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, neZinc. Washington, DC: National Academy Press, 2002. Itholakala ku: www.nap.edu/books/0309072794/html/.
  93. UPye KG, uKelsey SM, House IM, et al. I-dyserythropoeisis enamandla ne-autoimmune thrombocytopenia ehlotshaniswa nokufakwa kwesengezo se-kelp. ILancet 1992; 339: 1540. Buka okungaqondakali.
Kugcine ukubuyekezwa - 09/16/2020

Kudume Ku-Portal

Ukudla Okuhamba phambili Kokulwa neLabyrinthitis

Ukudla Okuhamba phambili Kokulwa neLabyrinthitis

Ukudla kwe-labyrinthiti ku iza ukulwa nokuvuvukala kwendlebe futhi kunciphi e ukuqala kokuhla elwa yi iyezi, futhi ku ekelwe ekwehli eni uku et henzi wa kuka hukela, i-pa ta iyonke, njenge inkwa nabaq...
I-Nafarelin (Synarel)

I-Nafarelin (Synarel)

INafarelin iyikhambi lamahomoni ngendlela ye ifutho e i hutheke emakhaleni futhi i ize ukunciphi a ukukhiqizwa kwe-e trogen ngama-ovari, oku iza ukunciphi a izimpawu ze-endometrio i .INafarelin ingath...